Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004230
What this trial is testing

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Who this might be right for
Cancer
Northwestern University 35
Large-scale testing (Phase 3)Study completedNCT01673867
What this trial is testing

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Who this might be right for
Non-Squamous Cell Non-small Cell Lung Cancer
Bristol-Myers Squibb 582
Not applicableStudy completedNCT00352391
What this trial is testing

Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Head and Neck CancerLung Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT04820023
What this trial is testing

Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment

Who this might be right for
NSCLC
Bridge Biotherapeutics, Inc. 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464327
What this trial is testing

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Who this might be right for
Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 450
Testing effectiveness (Phase 2)Study completedNCT00840125
What this trial is testing

Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment

Who this might be right for
Non-Small Cell Lung Cancer
Meir Medical Center 4
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242274
What this trial is testing

Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Jemincare 472
Testing effectiveness (Phase 2)Study completedNCT01281124
What this trial is testing

Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT00343720
What this trial is testing

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT02225405
What this trial is testing

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+2 more
M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824882
What this trial is testing

A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Who this might be right for
Non-Small Cell Lung Cancer
Hansoh BioMedical R&D Company 76
Not applicableStudy completedNCT04713462
What this trial is testing

Real-world Data of Nivolumab in Pre-treated NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Cooperative Oncology Group 346
Not applicableStudy completedNCT01124669
What this trial is testing

Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06003231
What this trial is testing

Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsEndometrial Neoplasms+1 more
Seagen, a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)UnknownNCT00238849
What this trial is testing

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

Who this might be right for
Previously Treated Metastatic Non-Small Cell Lung Cancer
Integrated Community Oncology Network 40
Early research (Phase 1)Study completedNCT02529995
What this trial is testing

Phase I, Study in Chinese NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive
AstraZeneca 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743723
What this trial is testing

IOV-5001 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerTriple Negative Breast Cancer (TNBC)+4 more
Iovance Biotherapeutics, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT04394624
What this trial is testing

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sanofi 31
Testing effectiveness (Phase 2)Study completedNCT02823990
What this trial is testing

TG4010 and Nivolumab in Patients With Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage II Non-Small Cell Lung Cancer+3 more
Megan Daly, MD 13
Testing effectiveness (Phase 2)UnknownNCT00033722
What this trial is testing

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Tularik
Next Page